Introduction
Under normal circumstances in mammals, only trace levels of Fe exist outside its physiological sinks i.e. transferrin, ferritin, heme, iron-sulfur clusters etc., where it is constantly shuttled between storage and reuse.
1,2 Excess Fe, particularly when it is uncomplexed, can catalyse the generation of harmful reactive oxygen species (ROS) through Fenton chemistry. 3 Thus, cellular Fe homeostasis is a crucial function. Humans are especially susceptible to Fe overload as they have no natural mechanism for Fe excretion.
4, 5 Irrespective of the cause of Fe overload (e.g. chronic blood transfusions in the treatment of b-thalassemia, Friedreich's ataxia etc.), the ROS that ensue from Fe-mediated redox reactions damage membranes, proteins and DNA, leading to pathology. For many years, the only Fe-chelating drug that was approved and widely utilised world-wide for the treatment of Fe overload was desferrioxamine B (DFO or desferal), a tri-hydroxamic acid which possesses high specificity for Fe III (Fig. 1 ).
potentially orally-active chelator, deferitrin ( Fig. 1) , has recently completed a Phase I human trial.
15
Our interest is in the development of chelators based on 2-pyridinecarbaldehyde isonicotinoyl hydrazone (HPCIH, Fig. 2 ) that show high Fe chelation efficacy in cell culture models and are orally effective in mice. [16] [17] [18] All analogues bear the 2-pyridinecarbaldehyde hydrazone backbone, which comprises pyridine-N, imine-N and carbonyl-O donor atoms forming a meridionally coordinating tridentate ligand (Fig. 2) . A number of HPCIH analogues have been synthesized to create a series with varying physicochemical properties, such as lipophilicity and ionisation constants.
16, 19 Given the high activity that some HPCIH analogues have shown in vitro 11, 16 and in vivo, 18 an investigation of their physicochemical properties and Fe coordination chemistry is clearly warranted. Previously, we showed that the parent compound of the series, HPCIH, was oxidised in aerated aqueous solution in the presence of Fe to afford N-(isonicotinoyl)-N -(picolinoyl)hydrazine (H 2 IPH, Fig. 1 ). 20 Interestingly, other closely related ligands of this series (e.g. 2-pyridinecarbaldehyde (4 -aminobenzoyl)hydrazone; HPCAH) did not undergo oxidation in the presence of Fe(II) or Fe(III), suggesting it was a reaction unique to HPCIH. 19 However, isolation and characterisation of Fe II complexes from the HPCIH series has been challenging, in contrast to the facile isolation and crystallographic characterisation of a number of other divalent first row transition metal complexes of HPCIH and HPC4AH (Mn, Co, Ni, Cu and Zn).
19
Here we report the first comprehensive investigation of the HPCIH analogues and their Fe II complexes. Moreover, we have synthesized a number of novel HPCIH chelators which are isomeric with other chelators from this family that have demonstrated activity in the past (e.g. HPCNH, HPCPH, HPC2BBH, HPC3BBH, Fig. 2 ). From these studies, we define important structure-activity relationships of the HPCIH analogues that should be noted for the design of future chelators for clinical use.
Experimental Syntheses
All commercially available chemicals and solvents used in this work were of analytical grade. Desferal TM (DFO) was from Novartis, Summit, NJ, USA.
Free ligands
The hydrazones were prepared via Schiff base condensation.
16,19
Recrystallisation from aqueous EtOH afforded pure ligand in >80% yield. Spectroscopic data for HPCIH and HPC4AH (formerly referred to as HPCAH) have been reported 19 4 . The crystals that formed were suitable for X-ray work and these were filtered off and air dried.
2-Pyridinecarbaldehyde nicotinoyl hydrazone (HPCNH·2H 2 O).
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Physical methods

Instrumentation
Solution UV/visible spectra were measured on a Perkin-Elmer Lambda 40 spectrophotometer. Infrared spectra were measured on a Perkin-Elmer Model 1600 FT-IR spectrophotometer with compounds being dispersed as KBr discs.
1 H NMR and 13 C NMR spectra were obtained with Bruker AC200F (200 MHz) and AV400 (400 MHz) instruments with TMS as internal standard for free ligand spectra or as an external standard contained within a capillary for 1 H NMR spectra of all Fe II complexes. Cyclic voltammetry was performed with a BAS100B/W potentiostat employing a glassy carbon or platinum working electrode and a platinum auxiliary electrode. 
Potentiometric titrations
Potentiometric titrations were performed with a Metrohm Titroprocessor under a nitrogen atmosphere in a water-jacketed chamber at 298 K as described. 19 The titrant was 0.1 M Et 4 NOH, standardised with HCl. Data were refined by a non-linear leastsquares refinement method using the program SuperQuad.
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Crystallography
Cell constants at 293 K were determined by a least-squares fit to the setting parameters of 25 independent reflections measured on an Enraf-Nonius CAD4 four-circle diffractometer employing graphite-monochromated Mo-Ka radiation (0.71073 Å ) and operating in the x-2h scan mode within the range 2 < 2h < 50 Å . The data set collected at 150 K employed an Oxford Cryosystems Cryostream Cooler (600 Series). Data reduction and empirical absorption corrections (w-scans) were performed with the WINGX suite of programs. 22 Structures were solved by direct methods with SHELXS and refined by full-matrix least-squares analysis with SHELXL-97. 23 All non-H atoms were refined with anisotropic thermal parameters, except C3B and C6B in the structure of [Fe(PC2BBH) 2 ]·1/2EtOAc where the data could only support partial anisotropic refinement due to the large number of parameters (two formula units in the asymmetric unit). Aryl and amino H-atoms were included at estimated positions using a riding model. Water and amide H-atoms (if any) were first located from difference maps then constrained at these positions in a similar manner to that employed for the remaining H-atoms. Molecular structure diagrams were produced with ORTEP3. 24 Crystal data are summarised in Table 1 .
Biological methods
Materials
Chelators were dissolved in DMSO as 10 mmol dm −3 stock solutions and diluted in medium containing 10% foetal calf serum (Commonwealth Serum Laboratories, Melbourne, Australia) so that the final [DMSO] < 0.5% (v/v). 25 Human SK-N-MC neuroepithelioma cells were from the American Type Culture Collection (Rockville, Maryland, USA) and cultured by standard procedures. 26 This latter cell type was used as the effects of chelators on its Fe metabolism are well characterised.
16,25,27
This journal is © 59 Fe to produce 59 Fe-transferrin ( 59 Fe-Tf) using established methods.
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Iron efflux and uptake experiments
The effect of the HPCIH chelators on the release of 59 Fe from SK-N-MC cells pre-labelled with 59 Fe-Tf and their ability to prevent 59 Fe uptake from 59 Fe-Tf were determined using standard procedures.
25,27,28 Briefly, efflux of 59 Fe from cells was examined after a 3 h preincubation of cells at 37
• C with 59 Fe-Tf ([Tf] = 0.75 lmol dm −3 ; [Fe] = 1.5 lmol dm −3 ). The cells were then washed four times with ice-cold phosphate buffered saline (PBS) followed by a 3 h reincubation at 37
• C in the presence of medium alone (control) or each of the chelators at 25 lmol dm −3 . The overlying medium was then removed and placed in c-counting tubes. The cells were removed from the culture dish in 1 cm 3 of PBS using a plastic spatula and added to separate c-counting tubes.
Internalised 59 Fe uptake from 59 Fe-Tf by SK-N-MC neuroepithelioma cells was examined in the presence of the chelators. Cells were incubated for 3 h at 37
• C with 59 Fe-Tf (
in the presence and absence of chelators (25 lmol dm −3 ). The cells were then washed four times with icecold PBS and incubated with ice-cold PBS containing the general protease, Pronase (1 g dm −3 ), for 30 min at 4 • C to separate internalised and membrane-bound 59 Fe. 26 Cells were removed from the substratum using a plastic spatula in the Pronase solution and centrifuged at 14000 × g for 1 min. The supernatant (membranebound 59 Fe) and pellet (internalised 59 Fe) were then separated using a Pasteur pipette and transferred to c-counting tubes for the determination of radioactive 59 Fe.
DNA plasmid degradation
The ability of the chelators to protect (or potentiate) DNA plasmid degradation in the presence of Fe II and H 2 O 2 was examined using published techniques. 17 The chelators were incubated for 30 min in the presence of Fe II (10 lmol dm −3 ), hydrogen peroxide (1 mmol dm −3 ) and plasmid DNA (10 lg cm −3 ) in the presence and absence of chelators. Samples were then loaded onto a 1% agarose gel and electrophoresed for 1 h at 90 V.
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Results and discussion
The HPCIH analogues: structure and properties
We previously published the crystal structures of the free ligands HPCIH, HPCBH, HPCFH 29 and HPCAH. 19 Here we report the additional crystal structures of HPCNH·2H 2 O, HPCPH, HPC2BBH·2H 2 O and HPC3HH (Fig. 3) .
The bond lengths and angles are as expected for compounds of this type. 29 In every case, the pyridyl N-atom was anti with respect to the imine N-atom, which avoids repulsion between the H-atoms attached to C4 and C6. As a consequence, the molecule is unfavourably disposed to coordinate a metal ion through the pyridyl N-atom (N1), imine N-atom (N2) and carbonyl O-atom (O1). Most of the ligands, including HPCIH, 29 are effectively planar with N1-C5-C6-N2, C6-N2-N3-C7 and N3-C7-C8-C9 torsion angles close to 180
• . However, the 2-bromophenyl ring in HPC2BBH is twisted about the C7-C8 bond, which may be attributed to the steric effect of the ortho Br atom, forcing the ring to rotate by a much greater extent than the other analogues.
The salts (H 2 PC3BBH)ClO 4 ·2H 2 O and (H 2 PC4BBH)ClO 4 ·H 2 O (Fig. 4) were crystallised from dilute perchloric acid solutions (pH 2). The pyridyl N-atom (N1) is identified as the site of protonation. Bond lengths and angles are not affected by the protonation as expected, which remain comparable to the rest of the ligands in the series. In contrast to HPC2BBH (Fig. 3) , the bromine atoms in (H 2 PC3BBH) + and (H 2 PC4BBH) + (Fig. 4 ) no longer impose any steric influence on the conformation of the phenyl ring and thus the molecules are virtually planar (N1-C5-C6-N2 and N3-C7-C8-C9 torsion angles at 180
• and 174.2 In contrast with the structures of the neutral hydrazones in Fig. 3 , the conformations of the protonated hydrazones are quite different. The pyridyl and imine N-atoms are now syn and the ligands are primed for tridentate coordination (Fig. 4) . Interestingly, a water molecule occupies the position normally taken by a coordinated metal ion, H-bonds replacing coordinate bonds in this instance. The water protons donate H-bonds to the imine-N and carbonyl-O atoms, while the water O-atom accepts an H-bond from the pyridinium NH group (Fig. 4) .
Protonation constants
Charged chelators (at physiological pH 7.4) are hindered in their passage across cellular membranes and cannot gain access to intracellular Fe pools nor can they be absorbed from the gut.
1,30
The protonation constants of the HPCIH series of ligands were determined and the results appear in Table 2 . The assignment of pK a values of ionisable protons in the HPCIH analogues conforms to reports of similar aroylhydrazones.
30-36
The first protonation constant (pK 1 ) is associated with the hydrazone N-NH-C=O group, while the lower pK a value (pK 2 ) is assigned to protonation of the 2-pyridyl ring, which is supported by crystallographic evidence reported here (Fig. 4) .
A significant inductive effect by the non-coordinating aromatic substituent on pK 1 is apparent. The electron-withdrawing isonicotinoyl group accounts for the low pK 1 value (9.17(1) for HPCIH). Conversely, the electron-donating 4-aminobenzoyl group accounts for the highest pK 1 value (11.63(3) for HPCAH). The value of pK 1 is important in determining the amount of ionised ligand at physiological pH (7.4) and also has a bearing on the proton-independent formation constants 19 (see below). In summary, most of the HPCIH analogues will be dominantly neutral at pH 7. 
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Fe complexes
The syntheses of Fe II complexes of the HPCIH analogues in pure form required carefully controlled conditions or else mixtures of mono-and bis-ligand complexes were obtained. Ferrous perchlorate was used as the salt, a large excess of triethylamine (20 equivalents) was added and the solvent was MeCN. This procedure was a successful general method to synthesise all FeL 2 complexes from the HPCIH analogues. A notable exception was HPCPH, where a partially oxidised di-Fe II , triple helical Fe 2 (L 2 L ) mixed ligand (hydrazone/hydrazine) complex was formed. 37 The peculiarities of this compound arise from participation of the 2-pyridyl N-donor adjacent to the carbonyl group. 37 No Fe complexes of this ligand are reported here.
Upon complexation of the HPCIH ligands, the IR vibrations involving the -HN-C=O-('amide') functional group of the hydrazone ligands were most affected.
38, 39 The NH proton is lost upon complexation and the amide group is converted to an enolate form i.e. -N-C=O-Fe. The carbonyl stretching frequency seen in the free ligands (1630-1700 cm −1 ) shifts to lower frequency. Given the complexity of the IR spectra in the range 1200-1600 cm −1 , an unambiguous assignment is difficult due to overlapping C=C and C=N vibrations from the aromatic rings. However, all Fe complexes exhibit a strong IR absorption at ca. 1380 cm −1 which was not observed in the free ligands and is probably due to the -N=C-O-Fe moiety.
The electronic spectra of the Fe II complexes of the HPCIH series in methanol were similar and each featured an intense, broad, asymmetric maximum at ca. 640 nm. By analogy with the closely related low spin Fe II complexes of the HPKIH analogues (Fig. 2) , 36 this transition is most likely of metal-to-ligand chargetransfer (MLCT) origin. All complexes exhibit intense ligandbased transitions in the near UV region at ca. 350 nm and 280 nm. A bathochromic shift is observed in these ligand-based transition bands as the aromatic substituent on the ligand becomes more strongly electron-donating. HPCAH, which bears the most strongly electron-donating substituents of the series, has the lowest energy maxima at 381 nm and 332 nm.
The 1 H NMR spectra of the Fe II complexes measured in d 6 -DMSO exhibited broad and downfield-shifted singlets for all protons (regardless of their environment) in contrast to the well resolved multiplets seen in the spectra of the free ligands. This feature is due to paramagnetism arising from a highspin/low-spin equilibrium in solution. No time dependence in the spectra was noted, so paramagnetic impurities from aerial oxidation of the complex can be ruled out. The number of peaks seen in each 1 H NMR spectrum was always less than the number of chemically distinct protons. The magnitude of the paramagnetic shift is indicative of the amount of high spin Fe II present and this varied considerably across the series. A full and accurate assignment of each NMR spectrum, as performed for the analogous Fe(PKIH) 2 series, 36 was not feasible but there are some clear trends apparent across the series of twelve Fe complexes. The non-coordinating aromatic/heterocyclic ring protons appear least affected by paramagnetism and are seen in the range of 7-10 ppm. The remaining peaks are considerably broader and appear well downfield (> 10 ppm). These correspond to the 4 pyridyl protons and the single azomethine proton. However, in no case were all 5 peaks seen. The complexes Fe(PCNH) 2 , Fe(PC4AH) 2 and Fe(PC3AH) 2 each exhibited 4 of the 5 expected peaks from the pyridine carbaldehyde moiety while all other complexes gave only 3 resonances with a large downfield shift. In our previous study with the Fe(PKIH) 2 analogues, 36 we showed that the proton most affected by paramagnetism was that in the 6-position of the coordinated pyridyl ring although in that case the paramagnetism was only very mild by comparison. Extrapolating to this system, we believe that the NMR resonance for the proton attached to atom C1 in Fig. 2 and 3 of all complexes was never seen in our NMR spectra due to an extremely large paramagnetic shift (and broadening). Thus the most downfield shifted proton of the four seen in the spectra of Fe(PCNH) 2 , Fe(PC4AH) 2 and Fe(PC3AH) 2 (the least paramagnetic compounds of this series) is presumably from the azomethine proton, which like the proton adjacent to the coordinated pyridyl N-atom is in closest proximity to the Fe ion and subject to the greatest influence of its paramagnetism.
The complex [Fe(PC2BBH) 2 ]·1/2EtOAc was successfully crystallised from ethyl acetate and its crystal structure determined at low temperature (150 K). The asymmetric unit comprises two complex molecules and a single ethyl acetate solvent molecule. Fig. 5 shows one complex molecule from the asymmetric unit. This bis-ligand complex is representative of the preferred binding mode of the HPCIH analogues and is the first bis-ligand Fe complex structurally characterised from this series. The coordination about Fe II can be described as distorted octahedral, with the two tridentate ligands arranged in a meridional fashion, orthogonal to each other. The bite angles defined by the two consecutive five-membered chelate rings of the coordinated hydrazone are ca. 80
• , thus resulting in the distorted octahedral coordination geometry. The bond lengths are characteristic of low spin Fe II and very similar to those reported for the related Fe II complexes of the HPKIH analogues.
36
In the Fe(PC2BBH) 2 complex, the 2-bromophenyl rings are twisted away from the plane of the ligands by ca. 45
• (Fig. 5 ), similar to that seen in the structure of the free ligand (Fig. 3) . The two complexes within the asymmetric unit exhibit slightly different conformations. In the molecule shown in Fig. 5 , one bromine atom (Br1B) is syn with respect to the carbonyl group, while the other (Br1A) is anti, whereas in molecule 2 (not shown) both bromine atoms are syn with respect to their adjacent carbonyl groups. 
Complex formation constants
The Fe II complex formation constants of the HPCIH series (in water) have been determined and are given in Table 3 . Equilibrium constants for the formation of both mono- ([FeL] + ) and bis-ligand (FeL 2 ) complexes were calculated. Under the conditions of the experiment, charge-neutral bis-ligand complexes of the typical formula Fe(PCIH) 2 are the prevailing species at physiological pH of 7.4, while mono-ligand complexes [Fe(PCIH] + begin to form at pH ≈ 3. This is significant, as it means that a bis-ligand Fe II complex formed within the cell may freely permeate the cell membrane to re-enter the plasma for excretion, since it carries no charge. 40 Hence, the neutral charge of the ligand and Fe complex may explain, at least in part, the high Fe chelation efficacy of many of these ligands, including HPCTH which has been examined in vitro and in vivo.
16,18
The pM scale (-log 10 [uncomplexed metal ion] at pH 7.4 after equilibration of 1 lmol dm −3 metal ion and 10 lmol dm (Table 3 ). The variation in pM values for the formation of Fe II complexes is relatively small across the HPCIH series. In fact, the small difference in affinity for Fe II among the HPCIH analogues is inadequate to account for the difference in their biological activity (see below). This clearly indicates that factors other than metal selectivity and affinity are responsible for the diversity in Fe chelation efficacy within the series and justify the assessment of factors such as lipophilicity, as described below.
The HPCIH analogues possess higher affinity for Fe II than does DFO (pM = 6.13). On the other hand, the high affinity of the hexadentate DFO for Fe III is rational, since it is a bacterial siderophore "designed" to sequester Fe III specifically, coordinating through six hard O-donors.
45, 46 In contrast, the HPCIH analogues coordinate through the pyridyl-N, imine-N and carbonyl-O atoms, furnishing a softer N 4 O 2 coordination sphere which leads to a preference for divalent over trivalent iron. Of note, the monobasic HPCIH analogues form charge-neutral bis-ligand complexes with divalent metal ions 19 (including Fe here).
Electrochemistry
In pure MeCN solution the Fe(PCIH) 2 analogue complexes displayed two reversible redox responses. The redox potentials are shown in Table 4 and a typical cyclic voltammogram of Fe(PCFH) 2 ) in MeCN, is illustrated in Fig. 6 . The higher potential voltammetric responses (E • between −200 mV and 0 mV vs. Fc +/0 (MeCN)) are assigned to the Fe III/II redox couple. The lower potential responses (Table 4) fall within a rather narrow range and their current magnitude is consistent with a net two electron process by comparison with the obligate single electron high potential (Fe III/II ) couple. The only redox active moiety common to the entire series (apart from the metal itself) is the coordinated 2-pyridyl ring. The two electron stoichiometry is indicative of overlapping single electron reductions of the coordinated pyridyl ligands i.e. there is no interaction between the two ligands and their redox potentials are too close to be resolved. This is similar behaviour to that reported in the electrochemistry of the related Fe(PKIH) 2 complexes. 36 Of note, is the significantly more negative potentials exhibited by Fe(PCAH) 2 . This is consistent with the strong electron-donating effect of the 4-aminophenyl substituent disfavouring both metal and ligand based reductions. At the other end of the series, Fe(PCIH) 2 displayed the most positive potentials, in this case most likely due to the strongly electron-withdrawing isonicotinoyl ring. A similar trend has been reported in the related Fe(PKIH) 2 series.
36
Electrochemistry of Fe(PCIH) 2 in a 1 : 1 mixture of DMF/water was investigated to provide more physiologically relevant redox potentials. Due to the limited aqueous solubility of the complexes, a minimum of 50% DMF was required to keep all complexes in solution and enable comparisons across the entire series. Due to the narrower potential window offered by this solvent, only the Fe III/II couple was investigated. Fig. 7 illustrates the cyclic voltammogram of Fe(PCIH) 2 in 1 : 1 DMF/water mixture at pH 7. All of the Fe(PCIH) 2 analogues displayed totally irreversible redox responses around 500 mV (vs. NHE) at pH = 7 (Table 4) that are consistent with a chemical reaction following oxidation (EC mechanism). Previously, we discussed this mechanism in the related Fe(PKIH) 2 analogues Fig. 7 (left) Cyclic voltammogram of Fe(PCIH) 2 in 50% aqueous DMF at pH 7 (sweep rate 100 mV s −1 ) and (right) proposed 'square' electrochemical scheme (only one coordinated ligand is shown for clarity but both are assumed to undergo the same reaction simultaneously).
and modelled the electrochemistry using digital simulation.
36,37
The proposed mechanism adapted to this system is also shown in Fig. 7 (right) . Briefly, in MeCN, only the reversible single electron exchange between compounds A and B (top line) was relevant. However, in the presence of water, the ferric complex undergoes rapid nucleophilic attack by hydroxide to produce compound C. The latter is reduced at a much lower potential (ca. 0 mV) to give compound D. Compound D is also unstable and eliminates water to restore the original Fe II complex A in a process that may be cycled indefinitely.
The electrochemistry of the other Fe(PCIH) 2 analogues in the same solvent was similar and in all cases a totally irreversible Fe III/II couple was identified. The redox potentials followed the same trend seen in the non-aqueous electrochemistry, indicating that the inductive effects of the non-coordinating aromatic rings are qualitatively similar in both water and MeCN. Due to the irreversibility of the Fe III/II couple in DMF : water, only the anodic peak potential is shown in Table 4 . It is notable that the peak position was sweep rate independent, thus the initial redox reaction is associated with a rapid heterogeneous electron transfer.
These results are very interesting when compared with those of the structurally similar Fe(PKIH) 2 analogues, where the ferric complexes underwent hydrolysis at a much slower rate (pseudo first order rate constants 2-50 s ) response in the vicinity of the initial anodic peak around 500 mV could be seen for the Fe(PCIH) 2 complexes. Thus, there was an order of magnitude increase in the rate of attack on the ferric complexes of the HPCIH analogues. The Fe III/II redox potentials of the Fe(PKIH) 2 complexes 36 are essentially the same as the corresponding couples for the Fe(PCIH) 2 analogues reported here. The only structural difference is the replacement of the non-coordinating 2-pyridyl group in the HPKIH analogues with an H-atom in the HPCIH series. Indeed, it is the C-atom to which these groups are attached that we propose is the target for nucleophilic attack by OH − and evidently this reaction occurs much more slowly in the HPKIH analogues. One obvious explanation is that the pyridyl ring provides steric hindrance to nucleophilic attack (compared with an H-atom). However, there could be an inductive effect from the 2-pyridyl ring that lowers the electrophilicity of the attached C-atom, but in the absence of other analogues bearing different substituents at this position it is difficult to comment further.
Partition coefficients
The rate of passive diffusion of a compound across biological membrane and into cells will be a function of lipophilicity, conveniently quantified by its partition coefficient (log P) between 1-octanol and water. 47 In previous studies on analogues of H 2 PIH
48,49
and deferiprone (L1) (Fig. 1) , 50 and also other Fe chelators, 51 it was observed that the relationship between Fe mobilisation activity and log P of these compounds depends not only on the partition coefficients of the ligands, but also on the partition coefficients of their Fe complexes. In this study, the 1-octanol-water partition coefficients of the HPCIH analogues and their Fe II complexes, respectively, were determined by published methods. 52 In the case of the Fe complex partition coefficients, all solutions were purged with nitrogen and sealed to prevent Fe II oxidation. The 1-octanolwater partition coefficients of the HPCIH analogues and their Fe II complexes are given in Tables 2 and 3 .
All of the HPCIH analogues have log P equal to or greater than 2 ( 
Cellular Fe efflux and uptake experiments
The ability of the HPCIH analogues to gain access to intracellular Fe is central to their potential use in the treatment of Fe overload. To examine the efficacy of a chelator to deplete cellular Fe pools we implemented established methods, namely Fe efflux and uptake experiments using SK-N-MC cells, to investigate this.
7,25,52,55, 56 The Fe efflux studies (Fig. 8A) assess the ability of a chelator to penetrate the cell membrane and bind and mobilize 59 Fe from intracellular Fe pools that have been pre-labelled by incubation with 59 Fe-Tf. This determines if a chelator can enter the cell and leave with cellular 59 Fe bound to it. We also examined the effects of the PCIH analogues at preventing cellular 59 Fe uptake from 59 Fe-Tf (Fig. 8B) . This latter property also necessitates membrane permeability and examines the ability of the ligand to compete with the cell for 59 Fe released from 59 Fe-Tf in the endosome. As internal controls, we have also assessed the well characterised Fe chelators, DFO and H 2 PIH (Fig. 1) . All the results are compared to control samples prepared in the absence of chelator.
As is evident from Fig. 8A , DFO showed only modest 59 Fe efflux activity (13% cellular 59 Fe release) relative to the control (7% cellular 59 Fe release with no chelator), which was consistent with our previous work. 16, 25, 57 This low activity was due to the hydrophilicity and low membrane permeability of DFO.
7,57 In contrast, H 2 PIH showed marked efficacy leading to the release of 69% of cellular 59 Fe which is ten-fold higher than the control (Fig. 8A) . In fact, H 2 PIH was the most effective chelator screened in this investigation and its activity was comparable to that observed in our previous studies.
25,27
All chelators from the HPCIH series except those with aminophenyl, hydroxyphenyl or furan substituents were significantly (p < 0.01) more effective than DFO in releasing 59 Fe from prelabelled cells (Fig. 8A) . No significant effects due to isomerism in the analogues with bromophenyl, hydroxyphenyl, aminophenyl and pyridyl groups in various positions were found. The most effective analogues were HPCIH, HPCNH, HPCPH, HPCBH and HPCTH.
The ability of the HPCIH analogues to inhibit cellular 59 Fe uptake from 59 Fe-Tf is shown in Fig. 8B . Note that in this case, an effective chelator will reduce uptake of 59 Fe from 59 Fe-Tf leading to a marked decrease of intracellular 59 Fe relative to the control without chelator. In agreement with previous studies, DFO showed very little activity at inhibiting 59 Fe uptake from Tf, 7,57 while H 2 PIH markedly reduced 59 Fe uptake to 25% of the control. As observed in the 59 Fe mobilisation study (Fig. 8A) , the HPCIH analogues bearing amino, hydroxyl or furoyl substituents were largely ineffective at preventing 59 Fe uptake from 59 Fe-Tf (Fig. 8B ). Chelators HPCBH, HPC2BBH, HPC3BBH, HPC4BBH and HPCTH were the most effective ligands of the HPCIH analogues. Indeed, the ligands showed efficacy comparable to H 2 PIH at preventing 59 Fe uptake from 59 Fe-Tf to 26-31% of the control (Fig. 8B) . 
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Considering these latter data showing that the best HPCIH analogues have comparable activity to H 2 PIH at preventing 59 Fe uptake, it is of interest that the ability of the HPCIH analogues at inducing 59 Fe mobilisation from cells was much less than H 2 PIH (Fig. 8A) 
44,60
In terms of the activity of the ligands in both 59 Fe mobilization and 59 Fe uptake assays, the most effective HPCIH series chelators were HPCBH and HPCTH which showed high activity in both studies. On inspection of their physical properties ( Table 2 ) and those of their Fe complexes (Table 3) , the intermediate log P values coupled with favourable ionisation constants that lead to charge neutral chelators and Fe II complexes appears to be an ideal combination for effective Fe chelation. On the other hand, it appears that hydrophilic substituents such as amino or hydroxyl, irrespective of their position on the phenyl ring, have a deleterious effect on Fe binding efficacy as found for other aroylhydrazones.
55
Hence, such groups as well as the furan substituent which also led to poor Fe chelation efficacy, should be avoided in the future design of ligands of this class. Hence, clearly the redox activity of the Fe complex is vital to determine for assessing its use as a clinically effective agent. The plasmid single and double strand-break assay was used to determine the ability of the chelators to cause DNA strand breaks through Fenton chemistry. For simplicity, comparisons between all the HPCIH analogues and controls were made based on the percentage of SC DNA remaining after the assay and these data are summarised in Fig. 9 and 10 . A number of different controls were used in these studies. 17 These included, plasmid treated with the restriction enzyme BamH1 which resulted in complete conversion to L DNA i.e. 0% SC DNA (Fig. 9, lane 2) ; untreated plasmid (Fig. 9, lane 3 ) and plasmid treated with hydrogen peroxide (Fig. 9, lane 4) that appeared on gels as primarily the SC DNA band. When plasmid II -mediated degradation assay of EDTA, DFO and all the HPCIH analogues examined in this study. The experimental procedure is the same as that described in Fig. 9 . Results are from a typical experiment of a total of 3 performed.
DNA plasmid degradation
was treated with Fe II and hydrogen peroxide (Fig. 9 , lane 5), SC DNA was partially converted to the OC form. We also examined various Fe to chelator stoichiometries in our study. These are represented here as so-called "iron binding equivalents" (IBE).
17
An IBE of one indicates a stoichiometric ratio of Fe to ligand such that the octahedral coordination sphere of Fe is satisfied (i.e. 1 Fe atom to 2 tridentate HPCIH ligands, or 1 Fe atom to 1 hexadentate DFO ligand etc). 17 An IBE of 0.1 indicates only about 10% of Fe will be complexed, while an IBE of 3 means that there will be an excess of uncomplexed ligand and this will favour complexation in the case where the formation constants are only modest (see Table 3 ).
In the presence of both Fe II and H 2 O 2 , both EDTA and DFO were protective of SC DNA at IBE of 3 ( Fig. 9 ; lanes 6 and 7, respectively), in agreement with previous work.
17, 66 However, HPCNH, HPCPH, HPC3AH and HPCIH in the presence of Fe II and H 2 O 2 stimulated plasmid degradation, leading to a marked decrease in SC DNA as the IBE increased to 3 ( Fig. 9; lanes 9-20) .
Comparisons between all the PCIH analogues were then made based on the %SC DNA remaining and the results of the gel quantified by scanning densitometry (Fig. 10) . Only results at IBEs of 1 and 3 are shown, as the results at an IBE of 0.1 were all similar to Fe II in the presence of H 2 O 2 . Of the HPCIH analogues, HPC3HH was the most damaging in terms of plasmid degradation, there being no SC DNA remaining at IBEs of 1 and 3 (Fig. 10) . Of the remaining analogues, HPCIH, HPC4BBH, HPC4HH, and HPCTH all reduced SC DNA to zero at an IBE of 3. On the other hand, HPCBH, HPC3BBH and HPC2BBH were far less damaging, with greater than 50% of SC DNA remaining at an IBE of 1.
These results were consistent with an earlier DNA degradation study of a smaller subset of the HPCIH analogues. 17 Single or double strand breaks in naked plasmid in this assay were due to Fe-catalysed redox activity and require the complex to be stable in both the divalent and trivalent forms. The ferrous complex of DFO is only formed at very low potential, and as such, it does not participate in Fenton chemistry. 67 Consequently, it shows no significant plasmid degradation activity.
However, redox activity does not necessarily mean that DNA plasmid degradation is inevitable.
17, 36 Redox-active Fe complexes that are negatively charged such as [Fe(EDTA)] 2− are repelled by like-charged DNA and show no significant plasmid degradation.
17, 36 All of the Fe(PCIH) 2 analogues degrade naked plasmid to some degree. Interestingly, the most damaging complexes result from ligands that possess potentially H-bond donating substituents (-OH, NH 2; Fig. 10 ). Ironically, these were also the least active at either mobilising intracellular 59 Fe (Fig. 8A ) or inhibiting 59 Fe uptake from 59 Fe-Tf (Fig. 8B) . We suggest that these potential H-bond donors promote association of the Fe complex with nucleic acid acceptor sites (phosphate, sugar etc.), whereas the analogues with the more hydrophobic groups (phenyl, bromophenyl) do not have a particularly great affinity for DNA.
In terms of the physiological significance of these results, it is important to note that the ability of an Fe-complexed chelator to degrade naked plasmid is only relevant if the complex can enter the nucleus. Previously, we showed 17 that although some of the Fe complexes of the HPCIH analogues were capable of degrading naked plasmid DNA in vitro, the damage to nuclear DNA in intact human cells was insignificant. This suggests that the Fe(PCIH) 2 complexes formed intracellularly do not gain access to DNA in the nuclear compartment.
Conclusions
This investigation represents the first systematic study of the Fe II coordination chemistry of the HPCIH analogues. This work was crucial, as this class of chelator shows great promise as an orally effective drug for the treatment of Fe overload disease.
16,18
